If You Invested $10K In Omega Healthcare Investors Stock 10 Years Ago, How Much Would You Have Now?
Omega Healthcare Investors Inc. (NYSE:OHI) is a real estate investment trust that primarily invests in skilled nursing and assisted living facilities in the U.S. and the U.K.
It is set to report its Q2 2025 earnings on July 31. Wall Street analysts expect the company to post EPS of $0.75, up from $0.71 in the prior-year period. According to Benzinga Pro, quarterly revenue is expected to reach $295.80 million, up from $252.75 million a year earlier.
Don't Miss:
Invest early in CancerVax's breakthrough tech aiming to disrupt a $231B market. .
Tired of Grid Failures and Charging Deserts? This Startup Has a Solar Fix and $25M+ in Sales —
The company's stock traded at approximately $34.79 per share 10 years ago. If you had invested $10,000, you could have bought roughly 287 shares. Currently, shares trade at $36.67, meaning your investment's value could have grown to $10,540 from stock price appreciation alone. However, Omega Healthcare also paid dividends during these 10 years.
Omega Healthcare's dividend yield is currently 7.31%. Over the last 10 years, it has paid about $27.11 in dividends per share, which means you could have made $7,792 from dividends alone.
Summing up $10,540 and $7,792, we end up with the final value of your investment, which is $18,332. This is how much you could have made if you had invested $10,000 in Omega Healthcare stock 10 years ago. This means a total return of 83.32%. However, this figure is significantly less than the S&P 500 total return for the same period, which was 256.40%.
Trending: Named a TIME Best Invention and Backed by 5,000+ Users, Kara's Air-to-Water Pod Cuts Plastic and Costs —
Omega Healthcare has a consensus rating of "Buy" and a price target of $36.28 based on the ratings of 20 analysts. The price target implies around 1% potential downside from the current stock price.
The company on May 1 announced its Q1 2025 earnings, posting FFO of $0.75, beating the consensus estimate of $0.74, while revenues of $276.80 million came in below the consensus of $288.69 million, as reported by Benzinga.
"We are pleased with our first quarter results, as we continue to grow FAD per share, while further de-levering the balance sheet. We have accretively invested approximately $423 million year-to-date through April 30th and, as a result, we are increasing our 2025 AFFO guidance to be between $2.95 and $3.01 per share from our previous guidance of between $2.90 and $2.98 per share," said CEO Taylor Pickett.
Check out this article by Benzinga for four analysts' insights on Omega Healthcare.
Given no expected upside potential, growth-focused investors may not find Omega Healthcare stock attractive. Conversely, the stock can be a good option for income-focused investors, who can benefit from the company's solid dividend yield of 7.31%.
Read Next:
Maximize saving for your retirement and cut down on taxes: .
, which provides access to a pool of short-term loans backed by residential real estate with just a $100 minimum.
Image: Shutterstock
This article If You Invested $10K In Omega Healthcare Investors Stock 10 Years Ago, How Much Would You Have Now? originally appeared on Benzinga.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
7 minutes ago
- Yahoo
Oil Dips as Traders Take Stock of US Tariffs and OPEC+ Shift
(Bloomberg) -- Oil slipped for the third time in four days as investors focused on the fallout from a wave of US trade levies and a decision by OPEC+ to restore more of the group's idled capacity. Are Tourists Ruining Europe? How Locals Are Pushing Back Trump's Gilded Design Style May Be Gaudy. But Don't Call it 'Rococo.' Denver City Hall Takes a Page From NASA In California, Pro-Housing 'Abundance' Fans Rewrite an Environmental Landmark Can Mamdani Bring Free Buses to New York City? Brent dipped toward $69 a barrel and West Texas Intermediate was below $68. President Donald Trump threatened new tariff rates on trading partners, while suggesting that he was still open to negotiations. The duties on countries including Japan and South Korea won't take effect until at least Aug. 1. 'Traders are watching Trump's new tariff threats and global growth risks, which could soften demand,' said Haris Khurshid, chief investment officer at Karobaar Capital LP. 'Looking ahead, we should be paying attention to any new OPEC+ signals about extending or adjusting supply cuts.' Oil closed higher on Monday after sliding at the open following a decision by OPEC+ to boost output more than expected in August. The group cited summer demand as one reason for their optimism that the barrels could be absorbed, and Saudi Arabia raised the price of its main crude grade to Asia. The oil market has been volatile in recent weeks after the war between Israel and Iran, with a fragile truce now in place, but tensions in the Middle East are starting to rise again following fresh attacks in the Red Sea. A second vessel was targeted near Yemen on Monday, hours after Iranian-backed Houthis claimed responsibility for an earlier attack on a ship in the same area. 'These attacks raise supply-chain costs and insurance premiums for oil cargoes,' said Khurshid. 'But unless there's a major supply disruption, the impact stays mostly at the margins.' Elsewhere, there are signs of tightness showing in the diesel market, as traders grapple with a summer supply squeeze. US stockpiles are at the lowest seasonally since 1996, while Europe benchmark futures signal a tighter market than during the height of the recent Israel-Iran conflict. SNAP Cuts in Big Tax Bill Will Hit a Lot of Trump Voters Too 'Telecom Is the New Tequila': Behind the Celebrity Wireless Boom For Brazil's Criminals, Coffee Beans Are the Target Sperm Freezing Is a New Hot Market for Startups Pistachios Are Everywhere Right Now, Not Just in Dubai Chocolate ©2025 Bloomberg L.P. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
7 minutes ago
- Yahoo
IvyPanda Launches AI-Powered Case Study Solver to Support Academic & Professional Analysis
Sheridan, Wyoming--(Newsfile Corp. - July 8, 2025) - IvyPanda, a company specializing in innovative tools and other educational resources, has introduced the AI Case Study Solver - an AI-driven solution that revolutionizes how case studies are approached. With this speedy tool, it's possible to do complex analysis on any topic quickly and receive clear, structured insights in mere seconds. IvyPanda - AI Case Study Solver "We've created the Case Study Analyzer to bridge the gap between complexity and clarity," says Hanna Sheremet, CEO of IvyPanda. "By automating the analysis process, we help students, educators, and professionals focus on deeper aspects of various cases and their actionable solutions." The IvyPanda Case Study Solver is ideal for anyone working with detailed case studies, whether in academia, research, medicine, business, or other fields. It's a universal tool for tackling challenging assignments, boosting the work process, and making accurate decisions. Who can benefit from the AI case study analyzer? Students can simplify academic assignments and instantly build a solid foundation for presentations or papers. Professionals can quickly break down business cases, healthcare reports, or legal scenarios for actionable insights. Educators can develop teaching materials or case study solutions more efficiently. Researchers can save time while focusing on deeper analysis and hypothesis testing. What makes the instrument special One of the Case Study Analyzer's standout features is its accessibility. IvyPanda has ensured that the tool is entirely free to use, with no registration or hidden costs. It's also unlimited, giving users the freedom to analyze multiple case studies without barriers. Other key features of the new tool are: AI-powered precision Customization opportunities Structured outputs User-friendly design Adaptability Using the Case Study Analyzer is simple: Paste up to 2,000 words of a case study into the tool. Add specific questions for targeted results (optional). Let the AI deliver a detailed analysis. In just a few moments, users receive structured summaries with identified challenges and actionable recommendations. The tool's advanced algorithms not only allow it to produce results quickly but also ensure clear and easy-to-understand output. All this makes the tool a perfect solution for users of all experience levels. About IvyPanda Since 2015, IvyPanda has been a trusted brand in academic support internationally. Headquartered in the US and Estonia, the company offers students and professionals a comprehensive suite of resources, from writing tools to study guides. IvyPanda's mission is to make learning smarter, more engaging, and more accessible for users worldwide. To learn more about the company and to try the Case Study Analyzer, visit the official website of IvyPanda. Hanna SheremetIvyPanda Study Hubwelcome@ To view the source version of this press release, please visit
Yahoo
12 minutes ago
- Yahoo
MP opposes warehouse scheme in open letter
An MP has shared an open letter opposing a warehousing scheme and urged local planners to "closely consider residents' voices". North Northamptonshire Council's planning committee is due to discuss an application for a 148-acre (60-hectare) site on greenfield land, north of Halden's Parkway Industrial Estate in Thrapston. Lee Barron, the MP for Corby and East Northamptonshire, said IM Properties Developments Ltd's application "fails to consider the impact this proposal will have on our communities". IM Properties said Mr Barron's letter was addressed to councillors and it would not be appropriate for it to comment on the planning process. In a report to the council's planning committee, council officers recommended the scheme for approval, subject to conditions including "the requirements of habitats regulations", as it would reduce nesting sites for birds. The report stated that 722 full-time jobs would be created under the plans, and the application "responds to strong market demand in the logistics sector". It added that more than 2,000 jobs could be expected "through direct, indirect and construction employment". The proposed site is close to the site of another warehousing scheme on Castle Manor Farm, to the east of the industrial estate, which is set to go before a planning inquiry on 22 July. In his letter, Barron said: "I would like to let residents know again that whilst I have no role in approving or rejecting this proposal, I stand against the plans." Barron said that the area "already faces challenges of road traffic and heavy goods vehicles breaching weight restrictions". Stantec, which was named in the council report as acting as the agent for the proposal, has also been approached for comment. Follow Northamptonshire news on BBC Sounds, Facebook, Instagram and X. Warehouse plan to go before council despite appeal Warehouse plans to go to government inquiry stage Campaigners oppose warehouses for rural areas North Northamptonshire Council Planning Inspectorate
